Lantern Pharma Inc.

NASDAQ: LTRN · Real-Time Price · USD
3.30
-0.13 (-3.79%)
At close: Jun 06, 2025, 3:59 PM
3.26
-1.21%
After-hours: Jun 06, 2025, 05:40 PM EDT

Lantern Pharma Statistics

Share Statistics

Lantern Pharma has 10.78M shares outstanding. The number of shares has increased by 0.24% in one year.

10.78M
0.24%
0%
23.23%
n/a
1,100
2.4%

Short Selling Information

The latest short interest is 254.84K, so 2.36% of the outstanding shares have been sold short.

254.84K
2.36%
2.68%
5.48

Valuation Ratios

0
-2.13
0
n/a
0
-1.93
0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Lantern Pharma.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 0.01, with a Debt / Equity ratio of 0.

0.01
0.01
0
-0.01
-0.01
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-865,883,875
24
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -42.17% in the last 52 weeks. The beta is 1.54, so Lantern Pharma's price volatility has been higher than the market average.

1.54
-42.17%
3.45
3.72
50.4
45,790

Income Statement

n/a
n/a
-22.22B
-20.78B
-20.59M
-20.78M
-1930.92
Full Income Statement

Balance Sheet

The company has 7.51M in cash and 243.66K in debt, giving a net cash position of 7.27M.

7.51M
243.66K
7.27M
-76.03B
21.1M
16.54M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -17.81M and capital expenditures -12.6K, giving a free cash flow of -17.83M.

-17.81M
-12.6K
-17.83M
-1.66
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

LTRN does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for LTRN is $25, which is 644% higher than the current price. The consensus rating is "Buy".

$25
644%
Buy
1
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-3.21
2